High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide study
Nephrology Dialysis Transplantation · 16.10.2026
DOI: 10.1093/ndt/gfag240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 16.10.2026. Verfasst von Faizan Mazhar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk, Swedish Research Council, Swedish Heart and Lung Foundation.
Abstract (Originalsprache)
Background and hypothesis The burden and prognostic significance of inflammation in chronic kidney disease (CKD) remains poorly characterized, with prior studies yielding conflicting estimates of the association between elevated high-sensitivity C-reactive protein (hsCRP) and cardio-kidney outcomes.
Methods
Observational nationwide study of 23 008 adults with CKD stages 3–5 attending nephrology care and enrolled in the Swedish Renal Registry (2008–2023). Inflammation was assessed longitudinally via 94 500 repeated hsCRP registrations. Time-varying, cause-specific Cox models accounting for competing risks estimated associations with study outcomes, which included major adverse cardiovascular events (MACE), heart failure (HF) hospitalization, acute kidney injury (AKI), kidney failure requiring replacement therapy (KFRT), and all-cause mortality. Pre-defined stratifiers were atherosclerotic cardiovascular disease (ASCVD) history and CKD stage.
Results
Mean age was 71 years, 65% were male, and median estimated glomerular filtration rate was 25 ml/min/1.73 m². Median hsCRP was 4.0 (interquartile range [IQR] 1.9–7.0) mg/l, and 75% of participants had hsCRP ≥2. Over median 3.9 (IQR 2.0–6.7) years, hsCRP ≥2 mg/l was associated with higher rates of all outcomes: hazard ratio 1.20 (95% confidence interval 1.12–1.28) for MACE (n = 5480 events), 1.29 (1.22–1.37) for HF hospitalization (n = 8173), 1.28 (1.18–1.38) for AKI (n = 3943), 1.09 (1.02–1.15) for KFRT (n = 6177), and 1.43 (1.37–1.50) for mortality (n = 12 645). In spline analyses, associations were steeper at lower hsCRP levels and flatter thereafter for all outcomes except KFRT, where the hsCRP-response relationship was relatively flat. Associations with MACE, HF, AKI, and mortality were consistent regardless of ASCVD status and CKD stage. Associations with KFRT were inconsistent across CKD stages.
Conclusion
In this nationwide cohort of adults with moderate to severe CKD receiving nephrology care, inflammation was common, and higher hsCRP levels were associated with adverse cardiovascular and kidney outcomes, as well as mortality. Although associations were less consistent for KFRT, these findings collectively support the utility of hsCRP monitoring in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Providence Medical Research Center, Providence Inland Northwest Health, Spokane, WA, USA.
- Nephrology Division and Kidney Research Institute, University of Washington School of Medicine, Seattle, WA.
- Novo Nordisk A/S, Søborg, Denmark.
- The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
- Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Katherine R Tuttle, Aurora Caldinelli, Brendon L Neuen, Marie Evans, Juan-Jesus Carrero
Förderung
- Novo Nordisk
- Swedish Research Council
- Swedish Heart and Lung Foundation
- Region Stockholm
Zitieren
APA
Mazhar, F., Han, M., Tuttle, K. R., Caldinelli, A., Fugger, M., Gerward, S., Mathisen, J., Neuen, B. L., Evans, M., & Carrero, J. J. (2026). High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide study. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfag240
Vancouver
Mazhar F, Han M, Tuttle KR, Caldinelli A, Fugger M, Gerward S, et al. High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide study. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfag240
BibTeX
@article{Mazhar2026,
author = {Mazhar, Faizan and Han, Minjung and Tuttle, Katherine R and Caldinelli, Aurora and Fugger, Magnus and Gerward, Sofia and Mathisen, Jimmi and Neuen, Brendon L and Evans, Marie and Carrero, Juan-Jesus},
title = {High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide study},
journal = {Nephrology Dialysis Transplantation},
year = {2026},
doi = {10.1093/ndt/gfag240}
}
EUVIMED